blue shield of california glp-1 Cross Blue plans reverse course on coverage GLP-1 weight loss drug options

However, this hypothesis is losing traction in light of emerging clinical data

Adjust doses : A doctor may recommend holding the dose steady longer or increasing it more

When you take a new medication, you want to minimize the downside and maximize the benefit

In adult NHANES (National Health and Nutrition Examination Survey) participants with diagnosed diabetes, glycemic control declined after more than a decade of progress, associated with a resurgence in vascular diabetic complications [23]

Obesity is a serious, common chronic disease among older Americans and Wegovy is the only weight management medicine proven to reduce the risk of major heart events, heart attack, stroke, or cardiovascular death in people with obesity and known heart disease